Lilly v. Warner

268 F. 156, 1920 U.S. Dist. LEXIS 872
CourtDistrict Court, E.D. Pennsylvania
DecidedSeptember 29, 1920
DocketNo. 1355
StatusPublished
Cited by3 cases

This text of 268 F. 156 (Lilly v. Warner) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lilly v. Warner, 268 F. 156, 1920 U.S. Dist. LEXIS 872 (E.D. Pa. 1920).

Opinion

THOMPSON, District Judge.

The plaintiff is a corporation engaged, at Indianapolis, Ind., in the manufacture and sale of pharmaceutical and chemical products. It employs a large staff of traveling sales agents in selling its product to druggists and physicians throughout the United States. In 1899 it commenced the manufacture and sale of a liquid preparation known as “Coco-Quinine.” It contains quinine as its therapeutic agent, and is designed for the administration of quinine sulphate in cases, where the liquid form is preferred to capsules or pills. Yerba santa is used in the compound to disguise [157]*157the bitterness of the quinine, and chocolate syrup is used for a coloring and flavoring medium. The formula is not patented, and the preparation is not the subject of a registered trade-mark. It is put up in bottles with a label, with the word “Tilly” in red script on a green background. The plaintiff, through its sales agents, was successful in introducing it and establishing extensive sale for it among pharmacists and dispensing physicians; that is, those who do not prescribe for their patients, but supply medicine from their own stock. The sales by druggists were upon physicians’ prescriptions and to customers who inquired for chocolate-quinine or Coco-Quinine.

The defendant is a Pennsylvania corporation, organized in 1908 to take over the long-established business of William R. Warner & Co., pharmaceutical and chemical manufacturers, and is chiefly owned and managed by Mr. Henry Pfeiffer, Mr. Gustavus A. Pfeiffer, and Mr. G. D. Merner, through holdings of its stock, and they are also the owners of the Pfeiffer Chemical Company and Searle & Hereth Company. For the purposes of this suit, the united control and the close union in business of these three companies is not disputed.

In 1906 the Pfeiffer Chemical Company put upon the market a.product known as “Quiri-Coco.” This product is practically identical with the plaintiff’s Coco-Quinine. It consists of quinine with yerba santa, vanillin, saccharin, and cocoa, with a syrup base. Since the organization of the defendant company in 1908 Quin-Coco has been manufactured by the Searle & Hereth Company and distributed solely by the defendant, the Warner Company.

The defendant has since its organization, through its sales agents, distributed and sold Quin-Coco as a substitute for Coco-Quinine. It has not attempted to sell it as Coco-Quinine, but has offered it and solicited orders for it from druggists as a substitute for Coco-Quinine and identical to 'it in therapeutic value. It is not established, nor is it claimed, that it is known to consumers as a product of Eli Rilly & Co. The use of chocolate to disguise quinine in tablet and lozenge form, and the use of yerba santa in the compound to disguise the bitterness of the quinine, was not new when the plaintiff made its preparation in liquid form, nor was the plaintiff the first discoverer of the use of chocolate for disguising quinine in liquid form. First in tablets or lozenges, and later in liquid form, the combination was known long prior to the manufacture of the plaintiff’s preparation.

The plaintiff’s bill is based upon the ground that it originated the product, and distinguished and identified it as its product, by the color and flavor of chocolate, which is not essential to its therapeutic value; •the chocolate being used for the sole purpose of making the remedy known by color and taste. It claims that chocolate is but one of many ingredients which could be used for this purpose, but by no means the sole medium. It claims that Coco-Quinine was the first successful preparation commercially known to physicians and druggists; that by legitimate business methods the plaintiff made it a distinctive and desired product throughout the United States, and won for it a high reputation with physicians, druggists, and the public in general; that into the market created by the plaintiff at great expense and effort [158]*158the defendant introduced Quin-Coco, by selling in that market a counterfeit of Coco-Quinine under a name resembling that used by the plaintiff for its genuine article; that the defendant’s product was sold as a substitute for plaintiff’s by unfair and dishonest means, supplying the counterfeit where the genuine was desired and called for, with the result that in numerous instances druggists filled prescriptions calling for Coco-Quinine with Quin-Coco, and sold Quin-Coco when they knew Coco-Quinine was desired. It is claimed that by these alleged deceptive and dishonest means the defendant acquired trade which had been built up by the efforts and at the expense of the plaintiff.

The plaintiff seeks an injunction restraining the defendant from the further manufacture and sale of a liquid preparation in the administration of quinine, or quinine in liquid form, colored or flavored with cocoa. It further seeks an injunction restraining the defendant from the use of the name “Quin-Coco” as a name designating such product, on the ground that it is a mere reversal of the words comprising file-name long used by the plaintiff for designating its product “Coco-Quinine.”

The effect of issuing an injunction would be to grant the plaintiff a monopoly, perpetual in effect, of the right to manufacture and sell a liquid preparation containing quinine, with its bitterness disguised by -the use of yerba santa, or some similar agent, if any exist, in combination with cocoa, which is chocolate less its fatty components, and which gives file preparation a distinctive color and flavor. The defendant contends that it can lawfully make and sell a substitute for any medicinal preparation, provided it does not do anything which would constitute “passing off” its product for that of another. The plaintiff, while conceding that it has no exclusive right to- the formula unless patented, and conceding further that it has no trade-mark, and that the defendant has not attempted to simulate the label upon its package, contends that because of the circumstance that, after its formula for a liquid preparation of quinine and yerba santa was satisfactorily worked out, it adopted the use of chocolate, so as to give the preparation a distinctive color and flavor, which would identify it as the plaintiff’s product, the public was, through unfair means, deceived through the defendant’s imitation containing the same color and flavor.

The plaintiff cites the case of Coca-Cola Co. v. Gay-Ola Co., 200 Fed. 720, 119 C. C. A. 164, and the authorities on which that decision is based, to sustain its position that the defendant may not use chocolate or cocoa for coloring the product because the plaintiff has used it to give its product a distinctive color and flavor. This contention, if the facts were such as to show acts on the part of the defendant to induce dealers to deceive the consumer into believing that it was getting the plaintiff’s product, would have support in the Gay-Ola Case, if the function of the chocolate were merely to give a distinctive color. The Gay-Ola product was colored by the use of caramel, and as stated by the court:

[159]*159“There is here no claim that caramel serves any other purpose in either compound, except merely to give color, and saying that it is one of the ‘component elements,’ as one of the witnesses does, is saying nothing more. It follows that the adoption, not only of caramel, hut of the selected amount of caramel, was for the main and primary purpose of malting the two articles look just alike.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

William R. Warner & Co. v. Eli Lilly & Co.
265 U.S. 526 (Supreme Court, 1924)
Eli Lilly & Co. v. Wm. R. Warner & Co.
275 F. 752 (Third Circuit, 1921)

Cite This Page — Counsel Stack

Bluebook (online)
268 F. 156, 1920 U.S. Dist. LEXIS 872, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lilly-v-warner-paed-1920.